News
1d
MedPage Today on MSNLorundrostat Lowered BP in Uncontrolled, Treatment-Resistant HypertensionParticipants with uncontrolled and otherwise treatment-resistant hypertension showed significant blood pressure improvement ...
By prioritizing innovation, community impact, and scalability, Saini has become a prominent figure not only in Kenya but ...
1d
Everyday Health on MSNTop Causes of Itchy Breasts and How to Find ReliefItchy breasts can be caused by a number of health issues. Learn what they are and how to effectively treat them.
Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with WHO Group 1 PAH FC 3 or 4 at high risk of mortality.
9d
News-Medical.Net on MSNPromising findings for the treatment of patients with pulmonary arterial hypertension with a high risk of mortalityPulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...
Dr. Richard Malish, M.D. is the new Chief Medical Director, a newly created position at the Arlington County Detention Facility. With over 30 years of service in the US Army and background in military ...
2d
Fintel on MSNWilliam Blair Downgrades Medpace Holdings (MEDP)Fintel reports that on April 22, 2025, William Blair downgraded their outlook for Medpace Holdings (NasdaqGS:MEDP) from ...
Dr. Donna Patterson's medical spa offers a solution to healthcare disparities by focusing on weight management and prevention ...
The Motley Fool. DATE Thursday, Apr 24, 2025 Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL PARTICIPANTS Rob Davis: Chairman and Chief ...
The incidence of heart diseases in Khyber Pakhtunkhwa (KP) is increasing at an alarming rate, leading to a serious health concern. According to the Peshawar Institute of Cardiology (PIC), in just one ...
McGuire, MD, MHSc, professor of medicine in the division of cardiology, Dallas Heart Ball ... SOUL results remained consistent regardless of background SGLT2 therapy (P for interaction ...
PURSUIT assessed efficacy and safety of four different doses of AZD0780, compared with placebo, in patients with hypercholesterolemia despite background statin therapy. The study, which was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results